Ethnic and Gender Differences in HPV Knowledge, Awareness, and Vaccine Acceptability Among White and Hispanic Men and Women

Overview

Journal J Community Health

Publisher Springer

Specialty Public Health

Date 2013 Oct 24

PMID 24150246

Citations 27

Authors

Rachel A Reimer

Julie A Schommer

Amy E Houlihan

Meg Gerrard

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to examine factors associated with human papillomavirus (HPV) knowledge and awareness, and HPV vaccination among White and Hispanic males and females. Differences in HPV knowledge, sources of information, vaccine awareness, vaccination status, and interest in vaccination were examined. A community sample was recruited from local health care clinics in a medium sized Midwestern city between May 2010 and December 2011. Participants (N = 507) were White (n = 243) and Hispanic, males (n = 202) and females between the ages of 15-30. Results indicate that White and female participants were significantly more likely to have heard of HPV, have higher levels of HPV knowledge, have been diagnosed with HPV, and be aware of the HPV vaccine for women. White and female participants were also more likely to have heard of HPV from their physician and were significantly more interested in receiving the HPV vaccine in the future. There was no effect of ethnicity on interest in the vaccine per a doctor's recommendation, however. Findings suggest that Whites and females have greater levels of HPV awareness and knowledge and that, while Hispanic participants are less likely than White participants to be told about the HPV vaccine from their provider, they may be equally receptive to such a recommendation.

Citing Articles

An Assessment of Young Adults' Awareness and Knowledge Related to the Human Papillomavirus (HPV), Oropharyngeal Cancer, and the HPV Vaccine.

Davis E, Doyle P Cancers (Basel). 2025; 17(3).

PMID: 39941716 PMC: 11816247. DOI: 10.3390/cancers17030344.

Human Papillomavirus (HPV)-Associated Cancers Among Hispanic Males in the United States: Late-Stage Diagnosis by Country of Origin.

Villalona S, Villalona S, Reinoso D, Sukhdeo S, Stroup A, M Ferrante J Cancer Control. 2023; 30:10732748231218088.

PMID: 38015627 PMC: 10685781. DOI: 10.1177/10732748231218088.

Assessing the Efficacy of the 3R (Reframe, Reprioritize, and Reform) Communication Model to Increase HPV Vaccinations Acceptance in Ghana: Community-Based Intervention.

Asare M, Agyei-Baffour P, Koranteng A, Commeh M, Fosu E, Elizondo A Vaccines (Basel). 2023; 11(5).

PMID: 37242995 PMC: 10223469. DOI: 10.3390/vaccines11050890.

Factors Associated with HPV Knowledge Among Professionals in the City of Francisco Beltrão, Brazil.

Grigolo A, Wendt G, Lucio L J Community Health. 2023; 48(4):652-658.

PMID: 36920712 DOI: 10.1007/s10900-023-01206-8.

HPV Vaccine Communication Competency Scale for Medical Trainees: Interdisciplinary Development Study.

Darville-Sanders G, Reinoso H, MacInnes J, Corluyan E, Munroe D, Mathis M JMIR Form Res. 2022; 6(11):e38164.

PMID: 36331545 PMC: 9675010. DOI: 10.2196/38164.

References

Markowitz L, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E . Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2):1-24. View

Myers E, McCrory D, Nanda K, Bastian L, Matchar D . Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000; 151(12):1158-71. DOI: 10.1093/oxfordjournals.aje.a010166. View

Zimet G, Mays R, Winston Y, Kee R, Dickes J, Su L . Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med. 2000; 9(1):47-50. DOI: 10.1089/152460900318957. View

Janicki D, Kamarck T, Shiffman S, Sutton-Tyrrell K, Gwaltney C . Frequency of spousal interaction and 3-year progression of carotid artery intima medial thickness: the Pittsburgh Healthy Heart Project. Psychosom Med. 2005; 67(6):889-96. DOI: 10.1097/01.psy.0000188476.87869.88. View

Reiter P, McRee A, Gottlieb S, Brewer N . HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 2010; 28(38):6292-7. PMC: 2931421. DOI: 10.1016/j.vaccine.2010.06.114. View

Gilbert P, Brewer N, Reiter P . Association of human papillomavirus-related knowledge, attitudes, and beliefs with HIV status: a national study of gay men. J Low Genit Tract Dis. 2010; 15(2):83-8. PMC: 4024215. DOI: 10.1097/LGT.0b013e3181f1a960. View

Davis K, Dickman E, Ferris D, Dias J . Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2005; 8(3):188-94. DOI: 10.1097/00128360-200407000-00005. View

. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. MMWR Morb Mortal Wkly Rep. 2012; 61(34):671-7. View

Reimer R, Houlihan A, Gerrard M, Deer M, Lund A . Ethnic differences in predictors of HPV vaccination: comparisons of predictors for Latina and non-Latina White women. J Sex Res. 2012; 50(8):748-56. DOI: 10.1080/00224499.2012.692406. View

10.

Hoover D, Carfioli B, Moench E . Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int. 2001; 21(5):375-91. DOI: 10.1080/07399330050082227. View

11.

Griffioen A, Glynn S, Mullins T, Zimet G, Rosenthal S, Fortenberry J . Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers. Clin Pediatr (Phila). 2012; 51(6):560-8. PMC: 3689424. DOI: 10.1177/0009922812443732. View

12.

Downs L, Smith J, Scarinci I, Flowers L, Parham G . The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008; 109(2 Suppl):S22-30. DOI: 10.1016/j.ygyno.2008.01.003. View

13.

Watson M, Saraiya M, Benard V, Coughlin S, Flowers L, Cokkinides V . Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008; 113(10 Suppl):2855-64. DOI: 10.1002/cncr.23756. View

14.

Dempsey A, Zimet G, Davis R, Koutsky L . Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006; 117(5):1486-93. DOI: 10.1542/peds.2005-1381. View

15.

Duggan C, Coronado G, Martinez J, Byrd T, Carosso E, Lopez C . Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women. BMC Cancer. 2012; 12:170. PMC: 3407514. DOI: 10.1186/1471-2407-12-170. View

16.

Allen J, Othus M, Shelton R, Li Y, Norman N, Tom L . Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010; 19(9):2187-98. DOI: 10.1158/1055-9965.EPI-10-0217. View

17.

Reiter P, McRee A, Kadis J, Brewer N . HPV vaccine and adolescent males. Vaccine. 2011; 29(34):5595-602. PMC: 3143221. DOI: 10.1016/j.vaccine.2011.06.020. View

18.

Colon-Lopez V, Ortiz A, Del Toro-Mejias L, Garcia H, Clatts M, Palefsky J . Awareness and knowledge of human papillomavirus (HPV) infection among high-risk men of Hispanic origin attending a sexually transmitted infection (STI) clinic. BMC Infect Dis. 2012; 12:346. PMC: 3529119. DOI: 10.1186/1471-2334-12-346. View

19.

Dunne E, Unger E, Sternberg M, McQuillan G, Swan D, Patel S . Prevalence of HPV infection among females in the United States. JAMA. 2007; 297(8):813-9. DOI: 10.1001/jama.297.8.813. View

20.

Baer H, Allen S, Braun L . Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research. J Community Health. 2000; 25(1):67-78. DOI: 10.1023/a:1005192902137. View